NINDS Investigator Goldstein Retires

Dr. David S. Goldstein, a senior investigator and chief of the autonomic medicine section in the Clinical Neurosciences Program at NIH’s National Institute of Neurological Disorders and Stroke (NINDS), recently retired after 47 years at NIH. For the past 14 years, he was also director of the Clinical Fellowship in Autonomic Disorders at NIH’s Clinical Center.

Goldstein is renowned as a founder and thought leader in autonomic medicine. He has substantial experience and expertise in clinical catecholamine neurochemistry, sympathetic neuroimaging, autonomic pathophysiology, mechanisms of catecholaminergic neurodegeneration and stress and homeostasis as medical scientific ideas. 

He received his bachelor’s from Yale College and M.D.-Ph.D. in behavioral sciences from Johns Hopkins University. After his internal medical residency at the University of Washington, Goldstein came to NIH as a clinical associate in NIH’s National Heart, Lung and Blood Institute (NHLBI) in 1978, obtaining tenure as a senior investigator in 1984. 

Goldstein joined NINDS in 1990 to head the clinical neurochemistry section and founded the clinical neurocardiology section (name changed to autonomic medicine Section in 2019). He has received Yale’s Angier Prize for Research in psychology, the Distinguished Investigator Award of the Society for Clinical and Translational Science, the NIH Distinguished Clinical Teacher Award, the Schatz Award of the American Academy of Neurology for research on autonomic disorders, and two NINDS Director’s Awards for mentorship. He is a fellow of the American Heart Association and the American Autonomic Society and a member of the Association of American Physicians. He is the author of more than 650 research articles and several books.